Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting adiponectin for cardioprotection.

Noriyuki Ouchi1, Rei Shibata, Kenneth Walsh

  • 1Molecular Cardiology/Whitaker Cardiovascular Institute, Boston University School of Medicine, 715 Albany Street, W611, Boston, MA 02118, USA.

Expert Opinion on Therapeutic Targets
|July 20, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mosaic Loss-of-Y Chromosome in Men Is Associated With Aortic Enlargement But Not Aortic Stenosis.

JACC. Advances·2026
Same author

Transient efferocytosis-induced activation of IKKβ reprograms macrophages to promote tissue resolution.

bioRxiv : the preprint server for biology·2026
Same author

PCPE-1 promotes cardiac fibrosis with aging and obesity.

JCI insight·2026
Same author

Tet2-driven clonal hematopoiesis drives aortic aneurysm via macrophage-to-osteoclast-like differentiation.

The Journal of clinical investigation·2026
Same author

Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association.

Circulation·2026
Same author

The Immunological Consequences of Clonal Hematopoiesis in Heart Failure.

Immunological reviews·2026
Same journal

The biological role of CCR4 and its ligands CCL17 and CCL22 in atopic dermatitis: therapeutic implications and future directions.

Expert opinion on therapeutic targets·2026
Same journal

Hepatocyte nuclear factor 4α - prospects for therapeutic targeting.

Expert opinion on therapeutic targets·2026
Same journal

The role of bile acid receptors in cholestatic liver disease: pathophysiological insights and therapeutic advances.

Expert opinion on therapeutic targets·2026
Same journal

Molecular insights for targeting the Nrf1 pathway in hepatocellular carcinoma.

Expert opinion on therapeutic targets·2026
Same journal

Transient receptor potential (TRP) channels: an emerging therapeutic target for the treatment of cardiac hypertrophy.

Expert opinion on therapeutic targets·2026
Same journal

The AT<sub>2</sub> receptor as a potential target for autosomal dominant polycystic kidney disease therapy?

Expert opinion on therapeutic targets·2026
See all related articles

Adiponectin, a protein from fat tissue, is lower in obesity. This protein shows anti-diabetic and anti-inflammatory effects, protecting against heart damage and remodelling, suggesting its potential as a heart-protective therapy.

Area of Science:

  • Endocrinology
  • Cardiology
  • Metabolic Syndrome

Background:

  • Adiponectin is an adipose tissue-derived plasma protein.
  • Reduced adiponectin levels are observed in obesity-related diseases.
  • Adiponectin possesses antidiabetic and anti-inflammatory properties.

Purpose of the Study:

  • To investigate the cardioprotective potential of adiponectin.
  • To explore adiponectin's role in mitigating cardiac complications.

Main Methods:

  • Review of experimental findings on adiponectin's effects on the heart.
  • Analysis of adiponectin's impact on cardiac remodelling and injury.

Main Results:

  • Adiponectin demonstrates protective effects against cardiac remodelling induced by pressure overload.

Related Experiment Videos

  • Adiponectin mitigates cardiac injury following ischaemia-reperfusion.
  • These actions highlight adiponectin's beneficial role in cardiovascular health.

    • Conclusions:

    • Adiponectin exhibits significant cardioprotective characteristics.
    • Adiponectin may serve as a potential therapeutic agent for various pathological heart conditions.
    • Further research into adiponectin-based therapies is warranted.